ANALYSIS OF ADVERSE EVENTS AFTER IMMUNIZATION WITH VACCINES AGAINST Sars-Cov-2
Abstract
Although the WHO-recommended coronavirus vaccines are safe and effective, vaccines provide new information to healthcare professionals about the extent and nature of adverse reactions to these drugs. The aim of the study is supplementing the available data on adverse reactions of vaccines on the example of the experience of vaccination of the teaching staff of the Cherkasy Medical Academy with vaccines COVISHIELD and COMIRNATY. Information for this study was collected retrospectively through a survey of 72 employees of the Cherkasy Medical Academy who were vaccinated with the COVISHIELD vaccine (first dose); 67 workers vaccinated with AstraZeneca (second dose); 54 workers who were vaccinated with COMIRNATY vaccine (first dose); 52 people vaccinated with this vaccine (second dose). The study confirmed that among the local side effects, the most common were pain at the injection site, among the systemic - fever, weakness, fatigue and drowsiness, headache, muscle pain, chills. Most of the side effects were most pronounced in young people, more often in women than in men.
References
“Italian study shows COVID-19 infections, deaths plummeting after jabs” (May 2021), Reuters. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/italian-study-shows-covid-19-infections-deaths-plummeting-after-jabs-2021-05-15/
Grover, N. (Aug 2021), “Jabbed adults infected with Delta ‘can match virus levels of unvaccinated’”, The Guardian. Retrieved from https://www.theguardian.com/world/2021/aug/19/jabbed-adults-infected-with-delta-can-match-virus-levels-of-unvaccinated
Remmel, A. (19 Febr 2021), “COVID vaccines and safety: what the research says”, Nature. Retrieved from https://www.nature.com/articles/d41586-021-00290-x
Hervé, C. L. (24 Sept 2019), “The how's and what's of vaccine reactogenicity”, Nature Partner Journals Vaccines. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31583123/
Larson, H. C. (2011), “Addressing the vaccine confidence gap”, Lancet. Retrieved from https://www.researchgate.net/publication/51211078_Addressing_the_Vaccine_Confidence_Gap
“COVID-19 vaccination: Side-effects” (12 Apr 2021), National Institute for Public Health and the Environment. Retrieved from https://www.rivm.nl/en/covid-19-vaccination/vaccines/side-effects
Moyer, M. W. (14 Apr 2021), “Women Report Worse Side Effects After a Covid Vaccine”, New York Times. Retrieved from: https://www.nytimes.com/2021/03/08/health/vaccine-side-effects-women-men.html
“Derzhavnyy ekspertnyy tsentr MOZ Ukrayiny oprylyudnyuye novyy shchotyzhnevyy zvit pro rezultaty sposterezhennya za bezpekoyu zastosuvannya vaktsyn proty Covid-19” [The State Expert Center of the Ministry of Health of Ukraine publishes a new weekly report on the results of monitoring the safety of vaccines against Covid-19] (2021), Derzhavnyy ekspertnyy tsentr MOZ Ukrayiny. Retrieved from: https://www.dec.gov.ua/materials/derzhavnyj-ekspertnyj-czentr-moz-ukrayiny-oprylyudnyuye-novyj-shhotyzhnevyj-zvit-pro-rezultaty-sposterezhennya-za-bezpekoyu-zastosuvannya-vakczyn-proty-covid-19-65/?role=patient
Shimabukuro, T. (27 Jan 2021), “COVID-19 vaccine safety update”. Advisory Committee on Immunization Practices (ACIP). Retrieved from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-01/06-COVID-Shimabukuro.pdf
“Coronavirus vaccine – weekly summary of Yellow Card reporting” (13 May 2021), Gov.uk. Retrieved from: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting
“ChAdOx1-S (rekombinantnaya) vaktsina ot COVID-19. Razrabotana Oksfordskim universitetomi proizvoditelyami AstraZeneca: Poyasnitelnaya zapiska po vaktsine ot COVID-19” [ChAdOx1-S (recombinant) COVID-19 vaccine. Developed by the University of Oxford and AstraZeneca Manufacturers: Explanatory Note on the COVID-19 Vaccine.] (7 Febr 2021), World Health Organization. Retrieved from: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21102_russian_astrazeneca_vaccine-explainer13b2736d-2427-4c9e-bd3c-0e8d8e1511dc.pdf?sfvrsn=ec951194_5
“Vse pro vaktsynatsiyu vid COVID-19 v Ukrayini” [All about vaccination against COVID-19 in Ukraine] (2021). Retrieved from: https://vaccination.covid19.gov.ua/#features-of-vaccines
Menni, C., Klaser, K., May, A., Polidori, L., Capdevila, J., Louca, P. et al. (27 Apr 2021), “Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study”. The Lancet: Infectious Diseases. Retrieved from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00224-3/fulltext
“Summary of Product Characteristics for Vaxzevria” (9 Sept 2021), Medicines and Halthcare products Regulatory Agency. Retrieved from: https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca#clinical-particulars
Jeong, M. “Oxford-AstraZeneca vaccine: What to know about side effects” (12 Apr 2021), Medical News Today. Retrieved from: https://www.medicalnewstoday.com/articles/oxford-astrazeneca-vaccine-what-to-know-about-side-effects
“COMIRNATY, mRNK-vaktsina ot COVID-19. Proizvoditel Pfizer Europe MA EEIG: Poyasnitelnaya zapiska – vaktsina ot COVID-19” [COMIRNATY, mRNA vaccine for COVID-19. Manufacturer Pfizer Europe MA EEIG: Explanatory Note - COVID-19 vaccine] (18 Jan 2021), World Health Organization. Retrieved from: https://cdn.who.int/media/docs/default-source/immunization/covid-19/21053_russian_vaccine-explainer_comirnaty.pdf?sfvrsn=b003116d_8
Polack, F.P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman. A., et al. (31 Dec 2020), “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine”, The New England Journal of Medicine. Retrieved from: https://www.nejm.org/doi/full/10.1056/nejmoa2034577
“Possible Side Effects After Getting a COVID-19 Vaccine” (2021), CDC: Centers for Disease Control and Prevention. COVID-19. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html
Chapin-Bardales, J., Gee, J., Myers, T. “Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines” (5 Apr 2021), JAMA Network. Retrieved from: https://jamanetwork.com/journals/jama/fullarticle/2778441
El-Shitany, N. A., Harakeh, S., Badr-Eldin, S. M., Bagher, A. M., Eid, B. G., Almukadi, H. S., et al. (19 Apr 2021), “Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study”, International Journal of General Medicine. Retrieved from: https://www.dovepress.com/minor-to-moderate-side-effects-of-pfizer-biontech-covid-19-vaccine-amo-peer-reviewed-fulltext-article-IJGM
Views:
266
Downloads:
164
Copyright (c) 2021 Stepanova H. M., Shevchenko O. T., Radziievska I. V
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
